April 2024
1. D'ANGELO SP, Araujo DM, Abdul Razak AR, Agulnik M, et al
   Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
   Lancet. 2024;403:1460-1471.
   

   >> Share

   
   January 2024
2. WEST EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al
   Complement in human disease: approved and up-and-coming therapeutics.
   Lancet. 2024;403:392-405.
   

   >> Share

   
   December 2023
3. THE LANCET
   The promise of genetic therapies in sickle cell disease.
   Lancet. 2023;402:2265.
   

   >> Share

   
   November 2023
4. BRADFORD DRR, Swift A, Allik M, McMahon AD, et al
   Physical health of care-experienced young children in high-income countries: a scoping review.
   Lancet. 2023;402 Suppl 1:S28.
   

   >> Share

   
   September 2023
5. ROBERTS I, Jones CP
   Structural racism and iron deficiency anaemia.
   Lancet. 2023;402:834-835.
   

   >> Share

   
   July 2023
6. AGARWAL N, Azad AA, Carles J, Fay AP, et al
   Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
   Lancet. 2023;402:291-303.
   

   >> Share

   
   
7. DASHRAATH P, Lim KMX, Chin HL, Sidek A, et al
   Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene.
   Lancet. 2023;402:141.
   

   >> Share

   
   June 2023
8. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
   Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
   Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
   

   >> Share

   
   May 2023
9. CONRAD N, Misra S, Verbakel JY, Verbeke G, et al
   Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
   Lancet. 2023 May 5:S0140-6736(23)00457-9. doi: 10.1016/S0140-6736(23)00457.
   

   >> Share

   
   April 2023
10. SHAND AW, Kidson-Gerber GL
    Anaemia in pregnancy: a major global health problem.
    Lancet. 2023 Apr 20:S0140-6736(23)00396-3. doi: 10.1016/S0140-6736(23)00396.
    

    >> Share

    
    
11. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    

    >> Share

    
    
12. PEPE J, Cipriani C, Colangelo L, Minisola S, et al
    Avascular necrosis in both hips in a patient with transfusion dependent beta-thalassaemia.
    Lancet. 2023;401:e19.
    

    >> Share

    
    January 2023
13. VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
    Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
    Lancet. 2023;401:269-280.
    

    >> Share

    
    
14. IKEDA K, Ueda K
    Gaining MOMENTUM against anaemic myelofibrosis.
    Lancet. 2023;401:248-249.
    

    >> Share

    
    November 2022
15. MICHAEL M, Bagga A, Sartain SE, Smith RJH, et al
    Haemolytic uraemic syndrome.
    Lancet. 2022;400:1722-1740.
    

    >> Share

    
    
16. MCDONAGH TA, Bromage DI, Cannata A
    Intravenous iron passes another endurance test in heart failure.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02180.
    

    >> Share

    
    
17. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    

    >> Share

    
    October 2022
18. SHIH MY, Wang JD
    Ghost cells are the spectre of fetal-maternal haemorrhage.
    Lancet. 2022;400:1223.
    

    >> Share

    
    September 2022
19. VAN GALEN LS, Simsek S
    Chilling to the marrow: finding extramedullary haematopoiesis in an unusual location behind the xiphoid.
    Lancet. 2022;400:e9.
    

    >> Share

    
    August 2022
20. KUO KHM, Layton DM, Lal A, Al-Samkari H, et al
    Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent alpha-thalassaemia or beta-thalassaemia: an open-label, multicentre, phase 2 study.
    Lancet. 2022;400:493-501.
    

    >> Share

    
    
21. KATTAMIS A
    An energy booster for thalassaemic red blood cells.
    Lancet. 2022;400:470-471.
    

    >> Share

    
    June 2022
22. KATTAMIS A, Kwiatkowski JL, Aydinok Y
    Thalassaemia.
    Lancet. 2022;399:2310-2324.
    

    >> Share

    
    January 2022
23. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    

    >> Share

    
    
24. VIGNESHWARAN J, Kumar MS, Raghavan V, Sundari S, et al
    Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Lancet. 2022;399:393.
    

    >> Share

    
    September 2021
25. LICHTSINN HS, Weyand AC, McKinney ZJ, Wilson AM, et al
    Sickle cell trait: an unsound cause of death.
    Lancet. 2021;398:1128-1129.
    

    >> Share

    
    
26. GURNARI C, Colak C, Zawit M, Maciejewski JP, et al
    Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria.
    Lancet. 2021;398:e14.
    

    >> Share

    
    February 2021
27. RICHARDS T, Clevenger B, Dahly D, Besser M, et al
    Iron deficiency in PREVENTT - Authors' reply.
    Lancet. 2021;397:670.
    

    >> Share

    
    
28. KEEGAN A, Crispin P, Ormerod A, Brown K, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:669.
    

    >> Share

    
    
29. FROESSLER B, Murphy E, Hodyl N
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668.
    

    >> Share

    
    
30. HOFMANN A, Gross I, Girelli D, Aapro M, et al
    Iron deficiency in PREVENTT.
    Lancet. 2021;397:668-669.
    

    >> Share

    
    January 2021
31. PASRICHA SR, Tye-Din J, Muckenthaler MU, Swinkels DW, et al
    Iron deficiency.
    Lancet. 2021;397:233-248.
    

    >> Share

    
    
32. GUILLAUME M, Lahary A, Zourdani L, Malandain E, et al
    A painless, sudden loss of vision in sickle cell anaemia: central retinal artery occlusion.
    Lancet. 2021;397:e1.
    

    >> Share

    
    
33. CRITCHLEY HOD, Munro MG, Shakur-Still H, Roberts I, et al
    Menstruation should not be overlooked in control of anaemia.
    Lancet. 2021;397:26.
    

    >> Share

    
    December 2020
34. MUNOZ M, Gomez-Ramirez S, Rondinelli MB, Weltert L, et al
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1884.
    

    >> Share

    
    
35. MYLES PS, Richards T, Klein A
    Preoperative intravenous iron for cardiac surgery.
    Lancet. 2020;396:1883-1884.
    

    >> Share

    
    November 2020
36. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    

    >> Share

    
    September 2020
37. ABRAMSON JS, Palomba ML, Gordon LI, Lunning MA, et al
    Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
    Lancet. 2020;396:839-852.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share